Company profile
Horizon Pharma company profile
Horizon Therapeutics operates as a biopharmaceutical company. It focuses on the development of prescription drugs for mild to moderate pain relief and arthritis. The company's product candidates include HZT-501, a proprietary fixed-dose combination formulation of NSAID and ibuprofen; and HZT-602, a combination oral drug product consisting of naproxen and famotidine. Horizon Therapeutics is based in Northbrook, Illinois, and was founded in 2005.
Business identity
- Contact email
- [email protected]
- Phone number
- +353 1 772 2100
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1,001-5,000 employees
- Revenue range
- $100M-$1B
- Founded
- 2005-01-01, Year
Headquarters
- Headquarters
- Attalla, Alabama, United States
- Postal code
- 60062
- Country code
- US
- Continent
- North America